A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren-Reference-Cited by-同舟云学术

A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren

Published:2015-11-16 Issue:11 Volume:10 Page:e0141658
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ozeki Yuriko,Igarashi Masayuki,Doe Matsumi,Tamaru Aki,Kinoshita Naoko,Ogura Yoshitoshi,Iwamoto Tomotada,Sawa Ryuichi,Umekita Maya,Enany Shymaa,Nishiuchi Yukiko,Osada-Oka Mayuko,Hayashi Tetsuya,Niki Mamiko,Tateishi Yoshitaka,Hatano Masaki,Matsumoto Sohkichi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. WHO. Available from: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf.

2. XDR tuberculosis—implications for global public health;MC Raviglione;N Engl J Med,2007

3. XDR tuberculosis: an indicator of public-health negligence;A Van Rie;Lancet,2006

4. Delamanid for multidrug-resistant pulmonary tuberculosis;MT Gler;N Engl J Med,2012

5. FDA approval of bedaquiline—the benefit-risk balance for drug-resistant tuberculosis;E Cox;N Engl J Med,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An efficient CRISPR interference-based prediction method for synergistic/additive effects of novel combinations of anti-tuberculosis drugs;Microbiology;2022-12-19

2. Direct Attachment with Erythrocytes Augments Extracellular Growth of Pathogenic Mycobacteria;Microbiology Spectrum;2022-04-27

3. Biosynthetic Interrogation of Soil Metagenomes Reveals Metamarin, an Uncommon Cyclomarin Congener with Activity against Mycobacterium tuberculosis;Journal of Natural Products;2021-02-23

4. Protein Kinase R Restricts the Intracellular Survival of Mycobacterium tuberculosis by Promoting Selective Autophagy;Frontiers in Microbiology;2021-01-22

5. New approaches for antituberculosis leads from Actinobacteria;Drug Discovery Today;2020-12